A detailed history of Moore Capital Management, LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Moore Capital Management, LP holds 100,000 shares of AGIO stock, worth $4.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
100,000
Previous 60,000 66.67%
Holding current value
$4.2 Million
Previous $2.59 Million 71.74%
% of portfolio
0.09%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$41.19 - $49.72 $1.65 Million - $1.99 Million
40,000 Added 66.67%
100,000 $4.44 Million
Q2 2024

Aug 14, 2024

BUY
$27.55 - $48.83 $1.65 Million - $2.93 Million
60,000 New
60,000 $2.59 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.3B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.